Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Peking Union Medical College Hospital
Age
18–45
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
The patients signed the written informed consent.
Histologically proven stage I, II, or III breast cancer
Must be candidates for adjuvant or neoadjuvant chemotherapy,
Must be premenopausal.
Trastuzumab is permitted in patients with human epidermal growth factor receptor 2 (HER2) overexpressing tumors.
You may not be if
The patients were previous chemotherapy;
Evidence of distant metastases;
Other malignancies in the previous 5 years.
The patients were using GnRHa, progesterone, stimulate ovulation drugs, oral contraceptives, aromatase inhibitors, intrauterine device with hormone, subcutaneous preparations contraceptive drugs such as hormone drugs and instruments during 3 month preceding the start of chemotherapy.
Pregnancy or lactation.
Clareo Health | Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer
